Singapore's Ministry of Health said that since the beginning of the year, it has been phasing in an extension of drug subsidies for intermediate and long-term care patients that allows them to buy their treatments at any approved point of care.
Instead of being limited to certain hospitals and clinics, patients can now buy drugs at subsidized rates from any ILTC provider, including a community hospital or even an at-home hospice care provider, Today Online reported.
The phase-in schedule, the ministry said, was designed to allow individual services to establish procurement arrangements with suppliers as they are able instead of making all wait until all have done so.
- here's the story from Today Online